• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

asperosaponin VI suppresses microglia activation and IDO activity

Martin aka paused||M.E.

Martin aka paused||M.E.

Senior Member
Messages
2,291
“ Our results propose a promising antidepressant effect for ASA VI possibly through the downregulation of IDO expression and normalization of the aberrant glutamate transmission. This remedying effect of ASA VI could be attributed to suppress microglia-mediated neuroinflammatory response via inhibiting the TLR4/NF-κB signaling pathway.”

https://link.springer.com/article/10.1007/s00213-020-05553-5

The question is if microglia activation in ME is driven by TLR or for example TGFb
 
You must log in or register to reply here.